Busulphan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia.
Russell
S
S
Bone Marrow Transplant Unit, Prince of Wales Children's Hospital, Sydney, Australia.
Vowels
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D006086:Graft vs Host Disease; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D012189:Retrospective Studies; D014916:Whole-Body Irradiation
D003561:Cytarabine; D003520:Cyclophosphamide; D002066:Busulfan; D008558:Melphalan